Matthew I. Milowsky
UNC Lineberger Comprehensive Cancer Center
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Renal cell carcinoma treatment
Most-Cited Works
- → Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma(2021)987 cited
- → Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology(2014)881 cited
- → Genome Sequencing Identifies a Basis for Everolimus Sensitivity(2012)688 cited
- → European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines(2023)582 cited
- → Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer(2005)507 cited
- → Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer(2013)420 cited
- → A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity(2017)393 cited
- → EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma(2020)315 cited
- → Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer(2004)313 cited
- → Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline(2022)310 cited